arrow_back Trending Legislation
Share share

Recognizing DES Drug Harm, Supporting Research, and Urging FDA Apology.

This resolution aims to officially acknowledge the historical health damage caused by the drug DES, which was administered to pregnant women until 1971. It calls for the restoration of funding for research into the long-term effects of this drug and urges the FDA to issue a formal apology to the affected families. This action supports individuals whose health was compromised by this toxic substance, including children exposed to cancer and fertility issues.
Key points
Support for restoring funding for the DES Follow-Up Study to investigate the long-term health consequences of exposure, crucial for affected generations.
Urging the Food and Drug Administration (FDA) to issue a formal apology to the millions of families impacted by the use of the DES drug.
Designating April 20-26 as DES Awareness Week to increase public knowledge about the risks and support those affected.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
Print number: HRES 342
Sponsor: Rep. McGovern, James P. [D-MA-2]
Process start date: 2025-04-21
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Recognizing DES Drug Harm, Supporting Research, and Urging FDA Apology.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HRES 342.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-21.

What are the main provisions?

Key points include:

  • Support for restoring funding for the DES Follow-Up Study to investigate the long-term health consequences of exposure, crucial for affected generations.
  • Urging the Food and Drug Administration (FDA) to issue a formal apology to the millions of families impacted by the use of the DES drug.
  • Designating April 20-26 as DES Awareness Week to increase public knowledge about the risks and support those affected.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McGovern, James P. [D-MA-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

Analysis and Potential Impact of HRES 342

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health